(18)FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients

BACKGROUND: The efficacy of neoadjuvant chemotherapy regimens in advanced luminal breast cancer patients is difficult to predict. Intrinsic properties of breast tumors, including altered gene expression profile and dynamic evaluation of metabolic properties of tumor cells using positron emission tom...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: de Cremoux, Patricia, Biard, Lucie, Poirot, Brigitte, Bertheau, Philippe, Teixeira, Luis, Lehmann-Che, Jacqueline, Bouhidel, Fatiha A., Merlet, Pascal, Espié, Marc, Resche-Rigon, Matthieu, Sotiriou, Christos, Groheux, David
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893244/
https://ncbi.nlm.nih.gov/pubmed/29662649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24674
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires